Related references
Note: Only part of the references are listed.Cholera toxin B induces interleukin-1β production from resident peritoneal macrophages through the pyrin inflammasome as well as the NLRP3 inflammasome
Takashi Orimo et al.
INTERNATIONAL IMMUNOLOGY (2019)
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial
Fatma Doener et al.
VACCINE (2019)
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity
Manuela Terrinoni et al.
SCIENTIFIC REPORTS (2019)
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review
Marie-Aleth Lacaille-Dubois
PHYTOMEDICINE (2019)
Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model
Leila Safari Zanjani et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2019)
Flagellin/NLRC4 Pathway Rescues NLRP3-Inflammasome Defect in Dendritic Cells From HIV-Infected Patients: Perspective for New Adjuvant in Immunocompromised Individuals
Edione Cristina dos Reis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Frequency and cost of live vaccines administered too soon after prior live vaccine in children aged 12 months through 6 years, 2014-2017
Karen A. Kirtland et al.
VACCINE (2019)
IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses
D. Lapuente et al.
MUCOSAL IMMUNOLOGY (2018)
Lysine-containing cationic liposomes activate the NLRP3 inflammasome: Effect of a spacer between the head group and the hydrophobic moieties of the lipids
Tianshu Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA
Ayako Wakabayashi et al.
CELL DEATH & DISEASE (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant
Jan Holmgren et al.
VACCINE (2018)
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Harm HogenEsch et al.
NPJ VACCINES (2018)
Understanding modern-day vaccines: what you need to know
Volker Vetter et al.
ANNALS OF MEDICINE (2018)
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Arnaud M. Didierlaurent et al.
EXPERT REVIEW OF VACCINES (2017)
From discovery to licensure, the Adjuvant System story
Nathalie Garcon et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
Annett Ziegler et al.
JOURNAL OF IMMUNOLOGY (2017)
Clostridium difficile flagellin FIiC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile
Jean-Francois Bruxelle et al.
PLOS ONE (2017)
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
Iain Welsby et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia et al.
NPJ VACCINES (2017)
Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response
Jillian A. Fontes et al.
IMMUNITY INFLAMMATION AND DISEASE (2017)
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Robyn Marty-Roix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The science of vaccine adjuvants: advances in TLR4 ligand adjuvants
Steven G. Reed et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
Sophie Detienne et al.
SCIENTIFIC REPORTS (2016)
Recent Advances in Subunit Vaccine Carriers
Abhishek Vartak et al.
VACCINES (2016)
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
Regina Heidenreich et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates
Jong R. Kim et al.
JOURNAL OF VIROLOGY (2015)
Identification of Aim2 as a Sensor for DNA Vaccines
John J. Suschak et al.
JOURNAL OF IMMUNOLOGY (2015)
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale et al.
VACCINES (2015)
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Mark D. Turner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Spectrum and Mechanisms of Inflammasome Activation by Chitosan
Chelsea L. Bueter et al.
JOURNAL OF IMMUNOLOGY (2014)
Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
Hao Xu et al.
NATURE (2014)
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells
Shlomo Z. Ben-Sasson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant
L. Martinez-Gil et al.
JOURNAL OF VIROLOGY (2013)
Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses
Silvia L. Lage et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TRPM2 links oxidative stress to NLRP3 inflammasome activation
Zhenyu Zhong et al.
NATURE COMMUNICATIONS (2013)
IL-1β Strikingly Enhances Antigen-Driven CD4 and CD8 T-Cell Responses
S. Z. Ben-Sasson et al.
IMMUNITY AND TOLERANCE (2013)
Molecular signature of the immune and tissue response to non-coding plasmid DNA in skeletal muscle after electrotransfer
C. J. Mann et al.
GENE THERAPY (2012)
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Vincent Compan et al.
IMMUNITY (2012)
Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin
Els F. Halff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
IL-1 Family Members IL-18 and IL-33 Upregulate the Inflammatory Potential of Differentiated Human Th1 and Th2 Cultures
Lars Blom et al.
JOURNAL OF IMMUNOLOGY (2012)
Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease
Sorina Georgiana Boaru et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
Inflammasomes in health and disease
Till Strowig et al.
NATURE (2012)
Sensing and reacting to microbes through the inflammasomes
Luigi Franchi et al.
NATURE IMMUNOLOGY (2012)
The Structure of the TLR5-Flagellin Complex: A New Mode of Pathogen Detection, Conserved Receptor Dimerization for Signaling
Jinghua Lu et al.
SCIENCE SIGNALING (2012)
Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis
Chelsea L. Bueter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus
Yue Zhao et al.
NATURE (2011)
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
Yvonne Dombrowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin
Matam Vijay-Kumar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
James Harris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Critical functions of priming and lysosomal damage for NLRP3 activation
Veit Hornung et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production
Hendrik Poeck et al.
NATURE IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
Zhiwei Sui et al.
VACCINE (2010)
Inflammasome recognition of influenza virus is essential for adaptive immune responses
Takeshi Ichinohe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR
I. Kimkong et al.
LUPUS (2009)
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Veit Hornung et al.
NATURE (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Shlomo Z. Ben-Sasson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
Liying Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanism of action of licensed vaccine adjuvants
Elaine Tritto et al.
VACCINE (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
Luigi Franchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
A calculated response: control of inflammation by the innate immune system
Gregory M. Barton
JOURNAL OF CLINICAL INVESTIGATION (2008)
Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
Mirjam Kool et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3
Hanfen Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Pierre Vandepapeliere et al.
VACCINE (2008)
Biological safety concepts of genetically modified live bacterial vaccines
Joachim Frey
VACCINE (2007)
Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response
J. Alain Kummer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release
Hanfen Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Bcl-2 and Bcl-XL regulate proinf lammatory caspase-1 activation by interaction with NALP1
Jean-Marie Bruey et al.
CELL (2007)
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination
David A. Zaharoff et al.
VACCINE (2007)
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation
Sanjeev Mariathasan et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Triggering TLR signaling in vaccination
D van Duin et al.
TRENDS IN IMMUNOLOGY (2006)
Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants
HF Stills
ILAR JOURNAL (2005)
Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro
KGK Murthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Roles of caspase-1 in Listeria infection in mice
NM Tsuji et al.
INTERNATIONAL IMMUNOLOGY (2004)
The interface between innate and adaptive immunity
K Hoebe et al.
NATURE IMMUNOLOGY (2004)
Flagellin acting via TLR5 is the major-activator of key signaling pathways leading to NF-κB and proinflammatory gene program activation in intestinal epithelial cells -: art. no. 33
T Tallant et al.
BMC MICROBIOLOGY (2004)
Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella
H Zeng et al.
JOURNAL OF IMMUNOLOGY (2003)
CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells
A Krug et al.
JOURNAL OF IMMUNOLOGY (2003)
Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice
Y Tal et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Freund adjuvant induces TLR2 but not TLR4 expression in the liver of mice
SK Lim
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Decoding the patterns of self and nonself by the innate immune system
R Medzhitov et al.
SCIENCE (2002)
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells
F Sierro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cytokines as adjuvants for the induction of mucosal immunity
PN Boyaka et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression
AT Gewirtz et al.
JOURNAL OF IMMUNOLOGY (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
VACCINE (2001)
Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu
K Nakanishi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells
TS Steiner et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen
M Eberl et al.
VACCINE (2000)